Day One Biopharmaceuticals
DAWN
DAWN
164 hedge funds and large institutions have $1.19B invested in Day One Biopharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 62 increasing their positions, 39 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $1.28B → $1.19B (-$96M)
11.94% less ownership
Funds ownership: 104.89% → 92.95% (-12%)
38% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $3.36M
Holders
164
Holding in Top 10
2
Calls
$2.08M
Puts
$3.36M
Top Buyers
| 1 | +$69.4M | |
| 2 | +$31.8M | |
| 3 | +$18.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$13.9M |
| 5 |
ECM
Estuary Capital Management
Wayzata,
Minnesota
|
+$12.3M |
Top Sellers
| 1 | -$35.6M | |
| 2 | -$29.4M | |
| 3 | -$26.8M | |
| 4 |
Goldman Sachs
New York
|
-$16.5M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$13.4M |